Article Text
Featured editorial
Evolution of the definition of myocardial infarction: what are the implications of a new universal definition?
Statistics from Altmetric.com
Footnotes
Funding: Research Grants>$10 000 from: Sanofi Aventis, Eli Lilly, Merck Sharpe & Dohme, Medicines Company, Neuren Pharmaceuticals, NIH, GlaxoSmithKline, Pfizer, Roche, Fournier Laboratories, Johnson & Johnson, Schering Plough, Janssen-Cilag; Consulting Fees: Medicure<$10 000, Medicines Company<$10 000, Neuren Pharmaceuticals<$10 000, GlaxoSmithKline<$10 000, Bayer<$10 000, Sanofi Aventis<$10 000; Speaker’s Honorarium: Sanofi Aventis<$10 000.
Competing interests: None.